NCT05556603View on ClinicalTrials.gov

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)

RecruitingOBSERVATIONAL
Enrollment

7,062

Participants

Timeline

Start Date

December 28, 2022

Primary Completion Date

June 30, 2029

Study Completion Date

December 31, 2029

Conditions
Cancer
Trial Locations (3)

200025

RECRUITING

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

Unknown

ACTIVE_NOT_RECRUITING

Huashan Hospital, Fudan University, Shanghai

ACTIVE_NOT_RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
collaborator

Guangzhou Burning Rock Dx Co., Ltd.

INDUSTRY

lead

Ruijin Hospital

OTHER